Access cutting-edge acute lymphoblastic leukemia treatment through this clinical trial at a research site in Buffalo. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Buffalo location
Preparing your pre-screening questions…
Access acute lymphoblastic leukemia specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related acute lymphoblastic leukemia treatment provided free
Check if you qualify for this acute lymphoblastic leukemia clinical trial in Buffalo, NY
No-Cost Study Care
Local to Buffalo
Convenient for NY residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This clinical trial identifies and addresses barriers to pediatric medication adherence among families of children with acute lymphoblastic leukemia. Pediatric nonadherence (noncompliance) to medication is a significant public health problem, and rigorous research repeatedly documents that nonadherence increases risk for hospitalization, healthcare cost, disease progression, and death. Pediatric acute lymphoblastic leukemia (ALL) patients who miss 5% of 6-mercaptopurine (6-MP) doses within the 2-year 6-MP regimen have a 2.7-fold risk of cancer that comes back after a period of improvement (relapse). To address these families' needs, researchers have developed MedSupport, a theory-based multilevel intervention with targets at the organizational, healthcare team, and caregiver levels that is designed to address root barriers to medication adherence. This study is being done to better understand families' experiences giving their child oral chemotherapy at home and to help families cope with the day-to-day challenges of giving their child medication.
Sponsor: Roswell Park Cancer Institute
Yes, this clinical trial (NCT06323044) has an active research site in Buffalo, NY that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for acute lymphoblastic leukemia treatment options in Buffalo, NY, this clinical trial (NCT06323044) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Buffalo research site is actively enrolling participants for this clinical trial. You'll receive care from experienced acute lymphoblastic leukemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all acute lymphoblastic leukemia clinical trials near you to find additional studies recruiting in your area.
See all leukemia clinical trials recruiting in Buffalo — not just this study.
Browse Leukemia Trials in Buffalo →